Interchange Capital Partners LLC Boosts Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Interchange Capital Partners LLC grew its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,310 shares of the biotechnology company’s stock after buying an additional 25 shares during the quarter. Interchange Capital Partners LLC’s holdings in Axon Enterprise were worth $779,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AXON. PNC Financial Services Group Inc. grew its holdings in Axon Enterprise by 17.5% during the third quarter. PNC Financial Services Group Inc. now owns 5,627 shares of the biotechnology company’s stock worth $2,249,000 after acquiring an additional 840 shares during the period. Jennison Associates LLC grew its holdings in Axon Enterprise by 48.2% during the third quarter. Jennison Associates LLC now owns 3,977 shares of the biotechnology company’s stock worth $1,589,000 after acquiring an additional 1,294 shares during the period. Massachusetts Financial Services Co. MA acquired a new stake in Axon Enterprise during the third quarter worth about $120,553,000. Great Valley Advisor Group Inc. grew its holdings in Axon Enterprise by 306.1% during the third quarter. Great Valley Advisor Group Inc. now owns 3,850 shares of the biotechnology company’s stock worth $1,539,000 after acquiring an additional 2,902 shares during the period. Finally, Penserra Capital Management LLC grew its holdings in Axon Enterprise by 12.6% during the third quarter. Penserra Capital Management LLC now owns 6,297 shares of the biotechnology company’s stock worth $2,516,000 after acquiring an additional 706 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $560.00 on Monday. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a market cap of $42.91 billion, a PE ratio of 144.70, a P/E/G ratio of 5.17 and a beta of 1.12. The stock has a 50 day moving average price of $591.90 and a 200 day moving average price of $543.57.

Analyst Ratings Changes

Several research firms recently commented on AXON. The Goldman Sachs Group raised their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Needham & Company LLC reiterated a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 26th. TD Cowen started coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. Finally, Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jeri Williams sold 307 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.